No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Nanopore sequencing products company Oxford Nanopore Technologies has filed an application in the US District Court for the Northern District of California for leave to serve subpoenas in support of a lawsuit it intends to file in the courts of England and Wales.
Oxford Nanopore said it filed an ex parte application that would allow it to serve Complete Genomics, Innomics, MGI Americas and others for breach of contractual obligations, claims for breach of common law obligations of confidence, breach of duties under the Trade Secrets Regulations 2018, and an entitlement claim to a license of certain patents./
Additionally, while not commenting on future litigation, Oxford Nanopore added that it does not believe BGI Tech Solutions' nanopore-based sequencing technology would be able to be used in commercial products around the world without infringing or misappropriating its own "substantial portfolio of proprietary rights".
As of 1005 BST, Oxford Nanopore shares were untraded at 144.10p.
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.